Mark Schoenberg - Chief Medical Officer at UroGen Pharma Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
URGN on Nasdaq
All Insider Reports
All Insider Reports

Mark Schoenberg - trading volume in the past year for UroGen Pharma Ltd.

Holdings reported by Mark Schoenberg for UroGen Pharma Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 144,985 $2,854,754 $19.69 03 Feb 2026 Direct
Restricted Stock Units 20,000 31 Jan 2026 Direct Ordinary Shares

Transactions reported by Mark Schoenberg for UroGen Pharma Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.